1Tanaka Y, Takeushi T, Mimori T, et al. Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. Ann Rheum Dis. 2010; 69(7): 1286-1291.
10.1136/ard.2009.121491
CAS PubMed Web of Science® Google Scholar
2Smolen JS, Nash P, Durez P, et al. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial. Lancet. 2013; 381(9870): 918-929.
10.1016/S0140-6736(12)61811-X
CAS PubMed Web of Science® Google Scholar
3Kaneko Y, Kato M, Tanaka Y, et al. Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised control study (the second year of the SURPRISE study). Ann Rheum Dis. 2018; 77(9): 1268-1275.
10.1136/annrheumdis-2018-213416
CAS PubMed Web of Science® Google Scholar
4Emery P, Burmester GR, Naredo E, et al. Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study. Ann Rheum Dis. 2020; 79(8): 1023-1030.
10.1136/annrheumdis-2020-217246
CAS PubMed Web of Science® Google Scholar
5Gandjbakhch F, Conaghan PG, Ejbjerg B, et al. Synovitis and osteitis are very frequent in rheumatoid arthritis clinical remission: results from an MRI study of 294 patients in clinical remission or low disease activity state. J Rheumatol. 2011; 38(9): 2039-2044.
10.3899/jrheum.110421
PubMed Web of Science® Google Scholar
6Brown AK, Conaghan PG, Karim Z, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008; 58(10): 2958-2967.
10.1002/art.23945
CAS PubMed Web of Science® Google Scholar
7Gandjbakhch F, Haavardsholm EA, Conaghan PG, et al. Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity. J Rheumatol. 2014; 41(2): 398-406.
10.3899/jrheum.131088
PubMed Web of Science® Google Scholar
8Ahmad HA, Baker JF, Conaghan PG, et al. Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept. Arthritis Res Ther. 2022; 24: 47.
10.1186/s13075-022-02735-8
CAS PubMed Web of Science® Google Scholar
9Tamai M, Arima K, Nakashima Y, et al. Baseline MRI bone erosion predicts the subsequent radiographic progression in early rheumatoid arthritis patients who achieved sustained good clinical response. Mod Rheumatol. 2017; 27(6): 961-966.
10.1080/14397595.2017.1294280
PubMed Web of Science® Google Scholar
10Jimenez-Boj E, Nöbauer-Huhmann I, Hanslik-Schnabel B, et al. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum. 2007; 56(4): 1118-1124.
10.1002/art.22496
CAS PubMed Web of Science® Google Scholar

Volume26, Issue12

December 2023

Pages 2559-2562

Magnetic resonance imaging including bone erosion may be useful for predicting disease flares in patients with rheumatoid arthritis: A hypothesis

CONFLICT OF INTEREST STATEMENT

Open Research

DATA AVAILABILITY STATEMENT

REFERENCES

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Magnetic resonance imaging including bone erosion may be useful for predicting disease flares in patients with rheumatoid arthritis: A hypothesis

CONFLICT OF INTEREST STATEMENT

Open Research

DATA AVAILABILITY STATEMENT

REFERENCES

References

Related

Information